Literature DB >> 20851801

The role of magnetic resonance imaging in oncology.

Concepción González Hernando1, Laura Esteban, Teresa Cañas, Enrique Van den Brule, Miguel Pastrana.   

Abstract

Conventional diagnostic magnetic resonance imaging (MRI) techniques have focused on improving the spatial resolution and image acquisition speed (whole-body MRI) or on new contrast agents. Most advances in MRI go beyond morphologic study to obtain functional and structural information in vivo about different physiological processes of tumor microenvironment, such as oxygenation levels, cellular proliferation, or tumor vascularization through MRI analysis of some characteristics: angiogenesis (perfusion MRI), metabolism (MRI spectroscopy), cellularity (diffusion-weighted MRI), lymph node function, or hypoxia [blood-oxygen-level-dependent (BOLD) MRI]. We discuss the contributions of different MRI techniques than must be integrated in oncologic patients to substantially advance tumor detection and characterization risk stratification, prognosis, predicting and monitoring response to treatment, and development of new drugs.

Entities:  

Mesh:

Year:  2010        PMID: 20851801     DOI: 10.1007/s12094-010-0565-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  102 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Multimodal imaging and computer assisted diagnosis for functional tumour characterisation.

Authors:  Hans-Ulrich Kauczor
Journal:  Cancer Imaging       Date:  2005-06-21       Impact factor: 3.909

3.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.

Authors:  G J Jager; E T Ruijter; C A van de Kaa; J J de la Rosette; G O Oosterhof; J R Thornbury; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

Review 4.  Diffusion-weighted magnetic resonance imaging and its application to cancer.

Authors:  Elizabeth M Charles-Edwards; Nandita M deSouza
Journal:  Cancer Imaging       Date:  2006-09-13       Impact factor: 3.909

5.  Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.

Authors:  L A Moulopoulos; D Gika; A Anagnostopoulos; K Delasalle; D Weber; R Alexanian; M A Dimopoulos
Journal:  Ann Oncol       Date:  2005-08-08       Impact factor: 32.976

Review 6.  Diffusion imaging for evaluation of tumor therapies in preclinical animal models.

Authors:  B A Moffat; D E Hall; J Stojanovska; P J McConville; J B Moody; T L Chenevert; A Rehemtulla; B D Ross
Journal:  MAGMA       Date:  2004-12-01       Impact factor: 2.310

Review 7.  Functional imaging of colorectal cancer angiogenesis.

Authors:  Vicky Goh; Anwar R Padhani; Shahnawaz Rasheed
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

8.  Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T.

Authors:  A D King; D K Yeung; A T Ahuja; E H Y Yuen; S F M Ho; G M K Tse; A C van Hasselt
Journal:  Clin Radiol       Date:  2005-05       Impact factor: 2.350

Review 9.  Imaging hypoxia and angiogenesis in tumors.

Authors:  Joseph G Rajendran; Kenneth A Krohn
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

10.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; Christoph Becker; Stefan Oswald Schoenberg; Nicola Lang; Reiner Bartl; Maximilian Ferdinand Reiser
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

View more
  9 in total

1.  Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging.

Authors:  Johan Coolen; Johan Vansteenkiste; Frederik De Keyzer; Herbert Decaluwé; Walter De Wever; Christophe Deroose; Christophe Dooms; Eric Verbeken; Paul De Leyn; Vincent Vandecaveye; Dirk Van Raemdonck; Kristiaan Nackaerts; Steven Dymarkowski; Johny Verschakelen
Journal:  Eur Radiol       Date:  2013-10-31       Impact factor: 5.315

2.  Using semi-quantitative dynamic contrast-enhanced magnetic resonance imaging parameters to evaluate tumor hypoxia: a preclinical feasibility study in a maxillofacial VX2 rabbit model.

Authors:  Linfeng Zheng; Yujie Li; Feng Geng; Sujuan Zheng; Ruiling Yan; Yuedong Han; Qiben Wang; Zhuoli Zhang; Guixiang Zhang
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  BOLD-MRI of breast invasive ductal carcinoma: correlation of R2* value and the expression of HIF-1α.

Authors:  Min Liu; Xiaojuan Guo; Shuangkun Wang; Mulan Jin; Ying Wang; Jie Li; Jun Liu
Journal:  Eur Radiol       Date:  2013-07-09       Impact factor: 5.315

4.  Quantitative T2*-Weighted Imaging and Reduced Field-of-View Diffusion-Weighted Imaging of Rectal Cancer: Correlation of R2* and Apparent Diffusion Coefficient With Histopathological Prognostic Factors.

Authors:  Yang Peng; Yan Luo; Xuemei Hu; Yaqi Shen; Daoyu Hu; Zhen Li; Ihab Kamel
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

5.  Full coverage path planning algorithm for MRgFUS therapy.

Authors:  Anastasia Antoniou; Andreas Georgiou; Nikolas Evripidou; Christakis Damianou
Journal:  Int J Med Robot       Date:  2022-03-13       Impact factor: 2.483

Review 6.  Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications.

Authors:  John Chang; Donald Schomer; Tomislav Dragovich
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

Review 7.  Functional magnetic resonance imaging in oncology: state of the art.

Authors:  Marcos Duarte Guimaraes; Alice Schuch; Bruno Hochhegger; Jefferson Luiz Gross; Rubens Chojniak; Edson Marchiori
Journal:  Radiol Bras       Date:  2014 Mar-Apr

8.  Estimation of T2* Relaxation Time of Breast Cancer: Correlation with Clinical, Imaging and Pathological Features.

Authors:  Mirinae Seo; Jung Kyu Ryu; Geon-Ho Jahng; Yu-Mee Sohn; Sun Jung Rhee; Jang-Hoon Oh; Kyu-Yeoun Won
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

9.  MR relaxation times of agar-based tissue-mimicking phantoms.

Authors:  Anastasia Antoniou; Leonidas Georgiou; Theodora Christodoulou; Natalie Panayiotou; Cleanthis Ioannides; Nikolaos Zamboglou; Christakis Damianou
Journal:  J Appl Clin Med Phys       Date:  2022-04-12       Impact factor: 2.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.